User:barryuxdc347472
Jump to navigation
Jump to search
Idactamab INT-001 represents a exciting medicinal strategy for treating certain hematologic cancers. The antibody is an unique mode of action, particularly targeting CD-38, the membrane antigen
https://nananhoj927377.blogdigy.com/idacta-mab-int-001-an-innovative-antigen-binding-protein-in-development-65374757